Exact Mass: 518.268
Exact Mass Matches: 518.268
Found 500 metabolites which its exact mass value is equals to given mass value 518.268
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Geranylfarnesyl diphosphate
Geranylfarnesyl diphosphate reacts with isopentenyl diphosphate to produce all-trans-hexaprenyl diphosphate and diphosphate. The reaction is catalyzed by a all-trans-hexaprenyl-diphosphate synthase enzyme. [HMDB] Geranylfarnesyl diphosphate reacts with isopentenyl diphosphate to produce all-trans-hexaprenyl diphosphate and diphosphate. The reaction is catalyzed by a all-trans-hexaprenyl-diphosphate synthase enzyme.
Dehydrodolichol diphosphate
This compound belongs to the family of Sesterterpenes. These are terpenes compsed of five consecutive isoprene units
Blumenol C O-[rhamnosyl-(1->6)-glucoside]
Blumenol C O-[rhamnosyl-(1->6)-glucoside] is found in fruits. Blumenol C O-[rhamnosyl-(1->6)-glucoside] is a constituent of quince (Cydonia vulgaris) leaves
Austalide G
Austalide G is a mycotoxin produced by Aspergillus ustu Mycotoxin production by Aspergillus ustus.
triglyceride palmitate
PA(2:0/20:3(6,8,11)-OH(5))
PA(2:0/20:3(6,8,11)-OH(5)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:3(6,8,11)-OH(5)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 5-hydroxyeicosatetrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(20:3(6,8,11)-OH(5)/2:0)
PA(20:3(6,8,11)-OH(5)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:3(6,8,11)-OH(5)/2:0), in particular, consists of one chain of one 5-hydroxyeicosatetrienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
4-(Acetyloxy)-2-[3,6-bis(acetyloxy)-4-[(acetyloxy)methylene]-5-hexenylidene]-6,10-dimethyl-5,9-undecadienal
2beta,3beta,6alpha,11beta-tetraacetoxy-ent-kaur-16-en-15-one|lushanrubescensin C
(1R*,2S*,3R*,5Z,7S*,8(17)Z,10R*,11R*,12S*,14S*)-3,14-diacetoxy-11,12-epoxy-18-oxobriara-5,8(17)-dien-2-yl butanoate
(1R*,2R*,4R*,5Z,7S*,8(17)Z,10R*,11R*,12S*,14S*)-4,14-diacetoxy-11,12-epoxy-18-oxobriara-5,8(17)-dien-2-yl butanoate
Ser Glu Lys Arg
Ser Glu Arg Lys
Thr Asp Lys Arg
Ala Arg Ser Trp
Ala Arg Trp Ser
Ala Ser Arg Trp
Ala Ser Trp Arg
Ala Trp Arg Ser
Ala Trp Ser Arg
Cys Ile Gln Arg
Cys Ile Arg Gln
Cys Leu Gln Arg
Cys Leu Arg Gln
Cys Gln Ile Arg
Cys Gln Leu Arg
Cys Gln Arg Ile
Cys Gln Arg Leu
Cys Arg Ile Gln
Cys Arg Leu Gln
Cys Arg Gln Ile
Cys Arg Gln Leu
Asp Glu Lys Lys
Asp Lys Glu Lys
Asp Lys Lys Glu
Asp Lys Arg Thr
Asp Lys Thr Arg
Asp Arg Lys Thr
Asp Arg Thr Lys
Asp Thr Lys Arg
Asp Thr Arg Lys
Glu Asp Lys Lys
Glu Lys Asp Lys
Glu Lys Lys Asp
Glu Lys Arg Ser
Glu Lys Ser Arg
Glu Arg Lys Ser
Glu Arg Ser Lys
Glu Ser Lys Arg
Glu Ser Arg Lys
Phe Lys Pro Gln
Phe Lys Gln Pro
Phe Pro Lys Gln
Phe Pro Gln Lys
Phe Gln Lys Pro
Phe Gln Pro Lys
Gly Met Arg Arg
Gly Arg Met Arg
Gly Arg Arg Met
Gly Arg Thr Trp
Gly Arg Trp Thr
Gly Thr Arg Trp
Gly Thr Trp Arg
Gly Trp Arg Thr
Gly Trp Thr Arg
Ile Cys Gln Arg
Ile Cys Arg Gln
Ile Met Gln Gln
Ile Gln Cys Arg
Ile Gln Met Gln
Ile Gln Gln Met
Ile Gln Arg Cys
Ile Arg Cys Gln
Ile Arg Gln Cys
Lys Asp Glu Lys
Lys Asp Lys Glu
Lys Asp Arg Thr
Lys Asp Thr Arg
Lys Glu Asp Lys
Lys Glu Lys Asp
Lys Glu Arg Ser
Lys Glu Ser Arg
Lys Phe Pro Gln
Lys Phe Gln Pro
Lys Lys Asp Glu
Lys Lys Glu Asp
Lys Pro Phe Gln
Lys Pro Gln Phe
Lys Gln Phe Pro
Lys Gln Pro Phe
Lys Arg Asp Thr
Lys Arg Glu Ser
Lys Arg Ser Glu
Lys Arg Thr Asp
Lys Ser Glu Arg
Lys Ser Arg Glu
Lys Ser Val Trp
Lys Ser Trp Val
Lys Thr Asp Arg
Lys Thr Arg Asp
Lys Val Ser Trp
Lys Val Trp Ser
Lys Trp Ser Val
Lys Trp Val Ser
Leu Cys Gln Arg
Leu Cys Arg Gln
Leu Met Gln Gln
Leu Gln Cys Arg
Leu Gln Met Gln
Leu Gln Gln Met
Leu Gln Arg Cys
Leu Arg Cys Gln
Leu Arg Gln Cys
Met Gly Arg Arg
Met Ile Gln Gln
Met Leu Gln Gln
Met Asn Arg Val
Met Asn Val Arg
Met Gln Ile Gln
Met Gln Leu Gln
Met Gln Gln Ile
Met Gln Gln Leu
Met Arg Gly Arg
Met Arg Asn Val
Met Arg Arg Gly
Met Arg Val Asn
Met Val Asn Arg
Met Val Arg Asn
Asn Met Arg Val
Asn Met Val Arg
Asn Arg Met Val
Asn Arg Val Met
Asn Thr Trp Val
Asn Val Met Arg
Asn Val Arg Met
Pro Phe Lys Gln
Pro Phe Gln Lys
Pro Lys Phe Gln
Pro Lys Gln Phe
Pro Gln Phe Lys
Pro Gln Lys Phe
Gln Cys Ile Arg
Gln Cys Leu Arg
Gln Cys Arg Ile
Gln Cys Arg Leu
Gln Phe Lys Pro
Gln Phe Pro Lys
Gln Ile Cys Arg
Gln Ile Met Gln
Gln Ile Gln Met
Gln Ile Arg Cys
Gln Lys Phe Pro
Gln Lys Pro Phe
Gln Leu Cys Arg
Gln Leu Met Gln
Gln Leu Gln Met
Gln Leu Arg Cys
Gln Met Ile Gln
Gln Met Leu Gln
Gln Met Gln Ile
Gln Met Gln Leu
Gln Pro Phe Lys
Gln Pro Lys Phe
Gln Gln Ile Met
Gln Gln Leu Met
Gln Gln Met Ile
Gln Gln Met Leu
Gln Arg Cys Ile
Gln Arg Cys Leu
Gln Arg Ile Cys
Gln Arg Leu Cys
Arg Ala Ser Trp
Arg Ala Trp Ser
Arg Cys Ile Gln
Arg Cys Leu Gln
Arg Cys Gln Ile
Arg Cys Gln Leu
Arg Asp Lys Thr
Arg Asp Thr Lys
Arg Glu Lys Ser
Arg Glu Ser Lys
Arg Gly Met Arg
Arg Gly Arg Met
Arg Gly Thr Trp
Arg Gly Trp Thr
Arg Ile Cys Gln
Arg Ile Gln Cys
Arg Lys Asp Thr
Arg Lys Glu Ser
Arg Lys Ser Glu
Arg Lys Thr Asp
Arg Leu Cys Gln
Arg Leu Gln Cys
Arg Met Gly Arg
Arg Met Asn Val
Arg Met Arg Gly
Arg Met Val Asn
Arg Asn Met Val
Arg Asn Val Met
Arg Gln Cys Ile
Arg Gln Cys Leu
Arg Gln Ile Cys
Arg Gln Leu Cys
Arg Arg Gly Met
Arg Arg Met Gly
Arg Ser Ala Trp
Arg Ser Glu Lys
Arg Ser Lys Glu
Arg Ser Trp Ala
Arg Thr Asp Lys
Arg Thr Gly Trp
Arg Thr Lys Asp
Arg Thr Trp Gly
Arg Val Met Asn
Arg Val Asn Met
Arg Trp Ala Ser
Arg Trp Gly Thr
Arg Trp Ser Ala
Arg Trp Thr Gly
Ser Ala Arg Trp
Ser Ala Trp Arg
Ser Lys Glu Arg
Ser Lys Arg Glu
Ser Lys Val Trp
Ser Lys Trp Val
Ser Arg Ala Trp
Ser Arg Glu Lys
Ser Arg Lys Glu
Ser Arg Trp Ala
Ser Val Lys Trp
Ser Val Trp Lys
Ser Trp Ala Arg
Ser Trp Lys Val
Ser Trp Arg Ala
Ser Trp Val Lys
Thr Asp Arg Lys
Thr Gly Arg Trp
Thr Gly Trp Arg
Thr Lys Asp Arg
Thr Lys Arg Asp
Thr Arg Asp Lys
Thr Arg Gly Trp
Thr Arg Lys Asp
Thr Arg Trp Gly
Thr Trp Gly Arg
Thr Trp Arg Gly
Val Lys Ser Trp
Val Lys Trp Ser
Val Met Asn Arg
Val Met Arg Asn
Val Asn Met Arg
Val Asn Arg Met
Val Arg Met Asn
Val Arg Asn Met
Val Ser Lys Trp
Val Ser Trp Lys
Val Thr His Tyr
Val Thr Asn Trp
Val Thr Trp Asn
Val Thr Tyr His
Val Trp Lys Ser
Val Trp Asn Thr
Val Trp Gln Ser
Val Trp Ser Lys
Val Trp Ser Gln
Val Trp Thr Asn
Val Tyr His Thr
Val Tyr Thr His
Trp Ala Asp Lys
Trp Ala Lys Asp
Trp Ala Arg Ser
Trp Ala Ser Arg
Trp Asp Ala Lys
Trp Asp Lys Ala
Trp Glu Gly Lys
Trp Glu Lys Gly
Trp Gly Glu Lys
Trp Gly Lys Glu
Trp Gly Arg Thr
Trp Gly Thr Arg
Trp Ile Asn Ser
Trp Ile Ser Asn
Trp Lys Ala Asp
Trp Lys Asp Ala
Trp Lys Glu Gly
Trp Lys Gly Glu
Trp Lys Ser Val
Trp Lys Val Ser
Trp Leu Asn Ser
Trp Leu Ser Asn
Trp Asn Ile Ser
Trp Asn Leu Ser
Trp Asn Ser Ile
Trp Asn Ser Leu
Trp Asn Thr Val
Trp Asn Val Thr
Trp Gln Ser Val
Trp Gln Val Ser
Trp Arg Ala Ser
Trp Arg Gly Thr
Trp Arg Ser Ala
Trp Arg Thr Gly
Trp Ser Ala Arg
Trp Ser Ile Asn
Trp Ser Lys Val
Trp Ser Leu Asn
Trp Ser Asn Ile
Trp Ser Asn Leu
Trp Ser Gln Val
Trp Ser Arg Ala
Trp Ser Val Lys
Trp Ser Val Gln
Trp Thr Gly Arg
Trp Thr Asn Val
Trp Thr Arg Gly
Trp Thr Val Asn
Trp Val Lys Ser
Trp Val Asn Thr
Trp Val Gln Ser
Trp Val Ser Lys
Trp Val Ser Gln
Trp Val Thr Asn
Tyr His Ile Ser
Tyr His Leu Ser
Tyr His Ser Leu
Tyr His Thr Val
Tyr His Val Thr
Tyr Ile His Ser
Tyr Ile Ser His
Tyr Leu His Ser
Tyr Leu Ser His
Tyr Ser His Ile
Tyr Ser His Leu
Tyr Ser Ile His
Tyr Ser Leu His
Austalide G
Blumenol C O-[rhamnosyl-(1->6)-glucoside]
all-trans-pentaprenyl diphosphate
Betamethasone butyrate propionate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor D004791 - Enzyme Inhibitors
[(2Z,6E,10E,14E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl] phosphono hydrogen phosphate
[(2Z,6Z,10Z,14E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl] phosphono hydrogen phosphate
(2S)-2-[[(2S)-2-[[(2S,3S,6R,7R)-2-amino-8-(2-amino-1-carbamoyl-4,5-dihydroimidazol-4-yl)-3-azaniumyl-6,7,8-trihydroxyoctanoyl]amino]propanoyl]amino]-3-methylbutanoate
(2S)-2-[[(2S)-2-[[(2S,3S,6R,7R)-2,3-diamino-8-(2-amino-1-carbamoyl-4,5-dihydroimidazol-4-yl)-6,7,8-trihydroxyoctanoyl]amino]propanoyl]amino]-3-methylbutanoic acid
[(2R)-1-acetyloxy-3-phosphonooxypropan-2-yl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
[(2R)-2-acetyloxy-3-phosphonooxypropyl] (6E,8E,11E)-5-hydroxyicosa-6,8,11-trienoate
longirostrerone C
An azaphilone that is 9,9a-dihydro-6H-furo[2,3-h]isochromene-6,8(6aH)-dione substituted by a 6-methyl-2-oxocyclohex-3-en-1-yl group at position 3, a methyl group at position 6a and a 4,6,8-trimethyldeca-2,4-dienoyl group at position 9. Isolated from Chaetomium longirostre, it exhibits cytotoxic and antimalarial activities.
3-(2,4-dimethoxyphenyl)-1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
3-(2,4-dimethoxyphenyl)-1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(2,4-dimethoxyphenyl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(2,4-dimethoxyphenyl)-1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(2,4-dimethoxyphenyl)-1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(2,4-dimethoxyphenyl)-1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(2,4-dimethoxyphenyl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(2,4-dimethoxyphenyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(2,4-dimethoxyphenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(2,4-dimethoxyphenyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(2,4-dimethoxyphenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
3-(2,4-dimethoxyphenyl)-1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
(3-Acetyloxy-2,7,7,11,15,17-hexamethyl-18-methylidene-5,13,16-trioxo-6,14-dioxatetracyclo[9.8.0.02,8.012,17]nonadecan-10-yl) acetate
2-cis,6-cis,10-trans,14-trans-Geranylfarnesyl diphosphate
pentaprenyl diphosphate
A polyprenol diphosphate compound having five prenyl units with undefined stereochemistry about the double bonds.
RF9 (hydrochloride)
RF9 hydrochloride is a potent and selective Neuropeptide FF receptor antagonist, with Ki values of 58 and 75 nM for hNPFF1R and hNPFF2R, respectively[1][2].